Po-cheng Shih

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Comparable 1-year effectiveness of tezepelumab and dupilumab after anti-IL-5/IL-5Rα biologic failure in severe asthma.

Comparable 1-year effectiveness of tezepelumab and dupilumab after anti-IL-5/IL-5Rα biologic failure in severe asthma.

Journal: European journal of internal medicine

Published: June 23, 2026

Beyond Vasodilation: Sotatercept and the Dawn of Disease Modification in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

Beyond Vasodilation: Sotatercept and the Dawn of Disease Modification in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

Journal: International journal of rheumatic diseases

Published: June 18, 2026

Cardiovascular Outcomes With Dupilumab Versus Omalizumab in Severe Asthma.

Cardiovascular Outcomes With Dupilumab Versus Omalizumab in Severe Asthma.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: May 04, 2026

Policy implications of mandatory systemic immunosuppressant trials prior to dupilumab for pediatric atopic dermatitis in Taiwan.

Policy implications of mandatory systemic immunosuppressant trials prior to dupilumab for pediatric atopic dermatitis in Taiwan.

Journal: Frontiers in pediatrics

Published: December 14, 2025

Chimeric Antigen Receptor T Cells in Autoimmune Disease: Mechanistic Insights, Safety Challenges, and Trial Design Imperatives.

Chimeric Antigen Receptor T Cells in Autoimmune Disease: Mechanistic Insights, Safety Challenges, and Trial Design Imperatives.

Journal: International journal of rheumatic diseases

Published: August 28, 2025

Beyond the Silence: Retinal Microvascular Signatures in Systemic Sclerosis Redefined.

Beyond the Silence: Retinal Microvascular Signatures in Systemic Sclerosis Redefined.

Journal: International journal of rheumatic diseases

Published: August 27, 2025

Live-Attenuated Influenza Vaccine in Pediatric: Safety Profile and Broader Implications for Immune-Mediated Diseases.

Live-Attenuated Influenza Vaccine in Pediatric: Safety Profile and Broader Implications for Immune-Mediated Diseases.

Journal: International journal of rheumatic diseases

Published: August 27, 2025

RE: Trends in young-onset cancer incidence: a modeling perspective.

RE: Trends in young-onset cancer incidence: a modeling perspective.

Journal: Journal of the National Cancer Institute

Published: August 26, 2025

The immunological mechanisms linking systemic lupus erythematosus and neuropsychiatric disorders.

The immunological mechanisms linking systemic lupus erythematosus and neuropsychiatric disorders.

Journal: Frontiers in immunology

Published: June 22, 2025

Large Language Models in Rheumatology: Prospects and Challenges for the Clinician.

Large Language Models in Rheumatology: Prospects and Challenges for the Clinician.

Journal: International journal of rheumatic diseases

Published: June 12, 2025

JAK Inhibitors: Therapeutic Prospects and Clinical Challenges in Sjögren's Syndrome.

JAK Inhibitors: Therapeutic Prospects and Clinical Challenges in Sjögren's Syndrome.

Journal: International journal of rheumatic diseases

Published: May 27, 2025

Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.

Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.

Journal: Therapeutic advances in musculoskeletal disease

Published: May 13, 2025

Showing 1-12 of 51

Last Updated: 09/26/2026